Regular stool tests already used in NHS care, combined with dietary information, could help identify people with inflammatory ...

Please provide your email address to receive an email when new articles are posted on . The AGA formulated 11 conditional recommendations to inform the use of biomarkers in the management of Crohn’s ...

A test that rapidly detects signs of inflammatory bowel disease (IBD) in stool samples could improve future diagnosis and ...

Age, fecal calprotectin level, toxin B polymerase chain reaction cycle threshold, immunosuppression, sex, and creatinine levels were identified as independent risk factors for developing recurrent ...

This prospective study in a large cohort of patients examined the use of calprotectin measurement in feces as a diagnostic test to identify clinically significant gastrointestinal findings in patients ...

The new approach, called “fasting mimicking,” improved symptoms among two-thirds of Crohn’s patients who tried it, ...

Two biomarker tests -- one for blood and the other for stool -- are mainstays in the treatment of inflammatory bowel disease (IBD), but gastroenterologists are hoping to gain even more insight from ...

Share on Pinterest Blood tests could be used more in the future in Crohn’s disease management. Bisual Studio/Stocksy More than half a million people in the United States live with Crohn’s disease. New ...